Latest filing published 02 May 2024 for Usana Health Sciences INC, €167k.
Filing timeline
BuySaleInsider track record
Daniel A. Macuga: trading record in brief
All filings by Daniel A. Macuga on record concern Usana Health Sciences Inc, in the capacity of senior executive. Over a trading history stretching from 13 February 2012 to 2 May 2024, the count stands at 113 filings.
On the market, this insider has only sold: 34 sales, €7.6M in total. Besides market trades, the filings include 28 share grants and 51 option exercises. Since January 2024: no purchases and 3 sales on the market.
Most recently, on 6 May 2024, the filings show an open-market sale worth €167k in Usana Health Sciences Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Daniel A. Macuga
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,791 shares@ US$47.142425.7% of flowCommon StockSEC:0000896264-24-000142:0
- 1,500 shares@ US$48.0810.3% of flowCommon StockSEC:0000896264-24-000100:0
- 710 shares@ US$50.850.4% of flowCommon StockSEC:0000896264-24-000071:1
- 1,676 sharesCommon StockSEC:0000896264-24-000071:0
- 1,580 sharesCommon StockSEC:0000896264-24-000051:2
- 1,061 shares@ US$47.800.6% of flowCommon StockSEC:0000896264-24-000051:1
- 670 shares@ US$49.710.4% of flowCommon StockSEC:0000896264-24-000051:3
- 2,503 sharesCommon StockSEC:0000896264-24-000051:0
- 1,006 shares@ US$47.230.5% of flowCommon StockSEC:0000896264-24-000031:1
- 2,201 sharesCommon StockSEC:0000896264-24-000031:0
- 2,234 shares@ US$62.8820.0% of flowCommon StockSEC:0001415889-23-009816:0
- 3,012 shares@ US$62.2227.2% of flowCommon StockSEC:0001415889-23-002831:0
- 670 shares@ US$59.760.5% of flowCommon StockSEC:0001415889-23-002181:1
- 711 shares@ US$61.530.5% of flowCommon StockSEC:0001415889-23-002181:3
- 1,677 sharesCommon StockSEC:0001415889-23-002181:2
- 1,581 sharesCommon StockSEC:0001415889-23-002181:0
- 955 shares@ US$60.040.7% of flowCommon StockSEC:0001415889-23-002056:1
- 492 shares@ US$60.040.3% of flowCommon StockSEC:0001415889-23-002056:3
- 1,160 sharesCommon StockSEC:0001415889-23-002056:2
- 2,200 sharesCommon StockSEC:0001415889-23-002056:0
- 1,474 shares@ US$53.917611.7% of flowCommon StockSEC:0001415889-22-012140:0
- 711 shares@ US$94.300.7% of flowCommon StockSEC:0001179110-22-000985:1
- 1,677 sharesCommon StockSEC:0001179110-22-000985:0
- 933 shares@ US$93.821.0% of flowCommon StockSEC:0001179110-22-000934:1
- 492 shares@ US$92.320.5% of flowCommon StockSEC:0001179110-22-000934:3
25 of 112 declarations
